Kala Pharmaceuticals 13G Filing Shows Checkpoint Capital (Master) Fund, LP Increased Stake In Co To 9.7%
Portfolio Pulse from Benzinga Newsdesk
Checkpoint Capital (Master) Fund, LP has increased its stake in Kala Pharmaceuticals to 9.7%, according to a recent 13G filing.
June 15, 2023 | 4:11 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Checkpoint Capital (Master) Fund, LP has increased its stake in Kala Pharmaceuticals to 9.7%, potentially leading to increased investor confidence.
The increased stake by Checkpoint Capital (Master) Fund, LP in Kala Pharmaceuticals indicates a strong belief in the company's potential. This could lead to increased investor confidence and a positive short-term impact on KALA's stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100